In silico analysis reveals PRDX4 as a prognostic and oncogenic marker in renal papillary cell carcinoma.

Gene(2023)

引用 1|浏览5
暂无评分
摘要
The data suggest that PRDX4 can be used as a prognostic marker for KIRP patients. Its association with more aggressive tumor characteristics also underlines that it might be used for targeted therapy.
更多
查看译文
关键词
PRDX4,Renal Papillary Cell Carcinoma,hypoxia,medical biology,molecular biology,oxidative stress,protein folding
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要